Mylan releases generic version of Focalin XR
Mylan Inc. has launched dexmethylphenidate hydrochloride extended-release capsules (30 mg), a medication for attention deficit hyperactivity disorder (ADHD). The company said Monday that the product, launched by its Mylan Pharmaceuticals Inc.